Since 2007
19 years of continuous editorial operation. Listings audited and re-audited as the directory ages — no stale 2008 records masquerading as live.
Some links on DirJournal are affiliate links. We only recommend verified businesses that clear our 12-point editorial audit standard.
Independent. Human-Curated. Established 2007.
Explore 8 Precision Medicine & Bio-Data Analysis entities audited against our 19-year editorial standard. We provide structured data and human-reviewed insights to separate high-authority providers from unverified search results.
List Your Business
Join 8 listed Precision Medicine & Bio-Data Analysis providers
Precision Medicine & Bio-Data Analysis currently lists 8 entities pending editorial audit.
Verified status arrives after a 12 point audit covering entity ownership, citation consistency across answer engines, schema validity, and operating history.
Ranking weights editorial tier and entity health score across the full listed set. No listings here carry the verification badge yet — they appear in order of editorial signal. Last updated .
San Diego, United States
Illumina is the world leader in next-generation sequencing and genomic analysis, providing platforms and services for whole genome sequencing, multi-omics research, and clinical precision medicine applications.
Invitae is a medical genetics company offering comprehensive genetic testing services for hereditary cancer, cardiovascular disease, neurological conditions, and rare diseases to guide clinical decision-making.
Why Trust DirJournal
19 years of continuous editorial operation. Listings audited and re-audited as the directory ages — no stale 2008 records masquerading as live.
Every entry clears a 12-point editorial audit before publication. No pay-to-play ranking — listing position reflects merit, not ad spend.
Schema-validated for ChatGPT, Gemini, and Perplexity. Machine-readable trust signals that AI engines parse and cite with confidence.
Join 8 listed Precision Medicine & Bio-Data Analysis providers. One payment, lifetime authority.
Secure Your $249.95 Permanent ListingGuardant Health develops liquid biopsy tests using cell-free DNA analysis for early cancer detection, therapy selection, and treatment monitoring, enabling minimally invasive precision oncology testing.